MetLife Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Sell |
|
|||||
|
2025
Q1 | $2M | Sell |
|
|||||
|
2024
Q4 | $2.5M | Buy |
|
|||||
|
2024
Q3 | $2.64M | Sell |
|
|||||
|
2024
Q2 | $2.84M | Buy |
|
|||||
|
2024
Q1 | $3.25M | Sell |
|
|||||
|
2023
Q4 | $2.94M | Sell |
|
|||||
|
2023
Q3 | $2.48M | Sell |
|
|||||
|
2023
Q2 | $2.73M | Sell |
|
|||||
|
2023
Q1 | $3.03M | Sell |
|
|||||
|
2022
Q4 | $3.3M | Sell |
|
|||||
|
2022
Q3 | $3.04M | Sell |
|
|||||
|
2022
Q2 | $3.34M | Sell |
|
|||||
|
2022
Q1 | $4.49M | Buy |
|
|||||
|
2021
Q4 | $4.2M | Sell |
|
|||||
|
2021
Q3 | $4.7M | Sell |
|
|||||
|
2021
Q2 | $4.31M | Sell |
|
|||||
|
2021
Q1 | $7.45M | Sell |
|
|||||
|
2020
Q4 | $6.8M | Sell |
|
|||||
|
2020
Q3 | $6.44M | Sell |
|
|||||
|
2020
Q2 | $5.12M | Buy |
|
|||||
|
2020
Q1 | $3.54M | Hold |
|
|||||
|
2019
Q4 | $4.28M | Sell |
|
|||||
|
2019
Q3 | $3.76M | Sell |
|
|||||
|
2019
Q2 | $4.1M | Sell |
|
|||||
|
2019
Q1 | $4.27M | Buy |
|
|||||
|
2018
Q4 | $3.32M | Sell |
|
|||||
|
2018
Q3 | $3.96M | Sell |
|
|||||
|
2018
Q2 | $3.38M | Buy |
|
|||||
|
2018
Q1 | $3.16M | Sell |
|
|||||
|
2017
Q4 | $3.28M | Buy |
|